Euronext Dublin Euronext Growth Dublin Suspension Notice (1150L)
04 September 2019 - 9:00AM
UK Regulatory
TIDMAMYT
RNS Number : 1150L
Euronext Dublin
04 September 2019
CORPORATE EVENT NOTICE: Suspension Notice
Amryt Pharma Plc
LOCATION: Dublin
DATE: 4th September 2019
MARKET: Euronext Growth
Trading of the under-mentioned securities of Amryt Pharma Plc
have been temporarily suspended, as detailed below.
Date and time of 2019-09-04T08:00:00Z
the communication
Action type Suspension of trading
------------------------------------------
Reasons for the action Due to the suspension of current clearing
arrangements and until such arrangements
have been restored.
------------------------------------------
Effective from 2019-09-04T08:00:00Z
------------------------------------------
Effective to
------------------------------------------
Ongoing True
------------------------------------------
Trading venue(s) XESM
------------------------------------------
Issuer name Amryt Pharma Plc
------------------------------------------
Issuer Legal Entity 213800BOS8WAJO2BEQ38
Identifier (LEI)
------------------------------------------
Instrument identifier GB00BKB1MS30
(ISIN)
------------------------------------------
Instrument full name Ordinary Shares
------------------------------------------
Sufficiently related
derivatives
------------------------------------------
Other related instruments
------------------------------------------
Comments
------------------------------------------
This announcement has been issued through the Companies
Announcement Service of Euronext Dublin.
The present notice and the contents thereof are only provided
for information purposes in order to facilitate the fair, orderly
and efficient functioning of the market and is not a recommendation
to engage in investment activities. The contents of this notice are
provided "as is" based on information provided to the market
operator without representation or warranty of any kind. Euronext
will not be held liable for any loss or damages of any nature
ensuing from using, trusting or acting on information provided. No
information set out or referred to in this notice shall form the
basis of any contract. The creation of rights and obligations in
respect of financial products that are traded on the exchanges
operated by Euronext's subsidiaries shall depend solely on the
applicable rules of the market operator.
The Euronext Markets comprise the markets operated by Euronext
Amsterdam, Euronext Brussels, Euronext Dublin, Euronext Lisbon,
Euronext Paris and Euronext UK Markets, referred to respectively as
the Amsterdam, Brussels, Dublin, Lisbon, Paris and London markets,
as relevant.
Euronext refers to Euronext N.V. and its affiliates. Information
regarding trademarks and intellectual property rights of Euronext
is located at https://www.euronext.com/terms-use.
(c) 2019 Euronext N.V. - All rights reserved
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEKMGGLNFLGLZM
(END) Dow Jones Newswires
September 04, 2019 03:00 ET (07:00 GMT)
Amryt Pharma (LSE:AMYT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Amryt Pharma (LSE:AMYT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
